Find investors
← Back to all investors
James Agnew
ResearchedAngel Investors

James Agnew

Partner

Angel InvestorsSeed Round
Pitch James

Get their honest, personalized take on your startup.

Sign in to pitch James

At a glance

Full Name
James Douglas Agnew
Title
Partner
Firm
Harwood Private Equity
Firm Type
Private equity
Investment Stage
Buyouts, expansion capital, buy-and-build/consolidation, and public-to-private transactions
Target Company Profile
Established small and medium-sized businesses, typically UK lower mid-market companies with enterprise value of £15 million to £75 million, high-quality management, maintainable earnings, market share, latent value, and growth potential
Sector Focus
Broad range of sectors including life sciences, biotechnology, multi-site leisure, precision manufacturing, financial services, media, healthcare components and services, packaging, pet care, electronic components, food and beverage, and insurance services
Geographic Focus
Primarily UK-headquartered investments; selected portfolio exposure in the US and Europe
Location
London, United Kingdom

Background

James Douglas Agnew is a Partner at Harwood Private Equity, the UK lower mid-market private equity arm within the Harwood Capital Management group. Harwood’s private equity funds invest in established small and medium-sized companies, with a long-running emphasis on buyouts, expansion capital, consolidation opportunities, and public-to-private transactions.

Agnew joined the Harwood Private Equity team in 2005. His firm biography states that he has more than 30 years of financial services experience and previously spent nine years in corporate finance at Credit Suisse First Boston before joining HPE. At Harwood, he leads transactions and serves as a non-executive director of several portfolio companies.

He holds a degree in accounting and finance from the University of Auckland. Companies House lists him as an active LLP member of Harwood Private Equity LLP, appointed on 21 February 2022, with a London correspondence address at 6 Stratton Street, Mayfair.

Investment Thesis & Focus

  • Harwood Private Equity invests in established small and medium-sized businesses, mainly in the UK lower mid-market, and seeks to back companies with strong potential and high-quality operational management.
  • The firm’s stated target company profile includes businesses with “high-quality operational management, maintainable earnings, decent market share, latent value and significant potential for growth.”
  • HPE targets companies with enterprise value between £15 million and £75 million.
  • The firm leads transactions using a low-leverage strategy and focuses on buyouts, expansion capital, buy-and-build opportunities, and public-to-private deals.
  • HPE has a specialist public-to-private practice, reporting 26 small-cap PTP transactions since 1999.
  • Harwood expects active ownership: it says it always joins portfolio company boards, supports management with finance and expertise, and works on financial controls, M&A, growth strategy, new contract wins, geographic expansion, and partner introductions.
  • The firm identifies an exit strategy before investing and has used trade sales, IPOs, and secondary private equity sales.

Notable Investments

  • APC Technology Group - Specialist technical distributor of electronic components and systems; Harwood invested in November 2019 via Fund 4 in a public-to-private transaction and exited the company in February 2026 to a European technology distributor.
  • Assisi Pet Care - Pet food and treats platform established to execute a roll-up in the pet sector; Harwood invested in September 2020 via Fund 5 and exited in October 2023 through a secondary buyout.
  • Medica Packaging / Medication Packaging Group - Manufacturer of printed cartons and folded leaflets for pharmaceutical and regulated markets; Harwood invested in December 2020 via Fund 5 and exited the group in July 2026 to Woodberry Packaging.
  • Source BioScience - Laboratory services business in genomics and histopathology; Harwood invested in December 2022 via Fund 5 in a public-to-private transaction.
  • Crest Foods - Illinois-based dairy stabiliser manufacturer and contract food packager; Harwood acquired the company in February 2024 via Fund 5.
  • CoventBridge - Provider of fraud, waste, and abuse investigative services in insurance, healthcare, and public sectors; Harwood invested in March 2016 via Fund 4 and completed a partial realisation in June 2026.
  • Tissue Regenix Group - Regenerative medicine products company; Harwood invested in December 2025 as the first investment of Harwood Private Equity VI.
  • Frenkel Topping Group - Specialist financial advice and services group; Harwood announced a recommended offer through Irwell Financial Services Bidco in September 2025.

Unlock the full research

Get how to approach them, recent activity, sources, contact links — plus pitch their AI twin for a candid read on your raise.

One-time. Stays unlocked for you.